Pharmacovigilance Services in Costa Rica

Pharmacovigilance is a fundamental component of the medicinal product lifecycle, ensuring that the safety, quality, and benefit-risk profile of authorised products continue to be monitored after market approval. Marketing Authorisation Holders (MAHs) and pharmaceutical companies are expected to establish robust pharmacovigilance systems that support the timely collection, evaluation, documentation, and reporting of safety information while meeting applicable regulatory obligations.

In Costa Rica, effective pharmacovigilance extends beyond regulatory compliance by enabling proactive safety surveillance, early detection of emerging risks, and informed regulatory decision-making. Whether commercialising innovative medicines, generic pharmaceuticals, biologics, biosimilars, vaccines, or combination products, organisations should maintain structured pharmacovigilance consulting processes that support adverse event reporting, signal detection, benefit-risk evaluation, and lifecycle compliance.

At DDReg, we provide Pharmacovigilance Services in Costa Rica to pharmaceutical manufacturers, biotechnology companies, Marketing Authorisation Holders, importers, distributors, and healthcare organisations seeking reliable regulatory and drug safety support. Our team combines scientific expertise with practical regulatory experience to develop compliant pharmacovigilance systems, manage post-marketing safety activities, and support organisations throughout the product lifecycle.

DDReg supports pharmacovigilance programmes for:

• Pharmaceutical manufacturers
• Biotechnology companies
• Generic medicine manufacturers
• Biologics and biosimilar companies
• Vaccine manufacturers
• Marketing Authorisation Holders (MAHs)
• Importers and distributors
• Contract Research Organisations (CROs)
• Healthcare companies expanding into Costa Rica

Our solutions are designed to support both individual medicinal products and multinational portfolios while integrating local regulatory expectations with global pharmacovigilance operations.

DDReg provides flexible pharmacovigilance solutions that strengthen existing safety systems or function as fully outsourced programmes, helping organisations maintain regulatory compliance and effective post-marketing surveillance.

• Pharmacovigilance Strategy and System Development

  Our specialists assess pharmacovigilance systems, governance frameworks, reporting processes, and regulatory responsibilities to identify compliance gaps and implement efficient programmes aligned with Costa Rican and international requirements. As part of our Costa Rica pharmacovigilance consulting services, we help organisations develop practical, compliant strategies that align with both local regulatory requirements and internationally recognised best practices.

• Adverse Event Management and ICSR Processing

  We support the complete lifecycle of Individual Case Safety Reports ( ICSRs Processing), including adverse event intake, medical review, MedDRA coding, quality review, follow-up, narrative preparation, safety database management, and regulatory reporting.

• Aggregate Safety Reporting and Benefit-Risk Evaluation

  Depending on organisational requirements DDReg supports aggregate safety reporting, medical review, safety trend analysis, and benefit-risk assessments to facilitate informed regulatory decisions and ongoing pharmacovigilance compliance.

• Signal Detection and Literature Monitoring

  Our team conducts signal detection by reviewing adverse event data, scientific literature, and other safety sources to identify potential risks and support continuous safety monitoring.

• Pharmacovigilance Documentation and Quality Systems

  We prepare and maintain inspection-ready pharmacovigilance documentation, including SOPs, pharmacovigilance agreements, quality management documents, CAPA records, compliance documentation, and audit support materials.

• Local Pharmacovigilance Support

  As a trusted Local Pharmacovigilance Provider in Costa Rica, DDReg supports local safety coordination, regulatory communication, country-specific reporting, and integration with global pharmacovigilance programmes.

• Drug Safety Services and PV Outsourcing

  Our Drug Safety Services in Costa Rica support post-marketing surveillance, safety reporting, benefit-risk evaluation, and lifecycle pharmacovigilance. Through our PV Outsourcing Services in Costa Rica, organisations can outsource selected pharmacovigilance activities or fully managed programmes while maintaining regulatory compliance and operational flexibility.